Hepatitis A Antibody Seroprevalence in Chronic Liver Disease Patients | ||
| Aswan University Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 03 March 2025 | ||
| Document Type: Review Articles | ||
| DOI: 10.21608/aumj.2025.360200.1194 | ||
| Authors | ||
| Noha Salah Fatim* 1; Awny Ali Abdelrahman1; Mahmoud Gamal Elagramy2; Sahar Hassany3 | ||
| 1Gastroenterology and tropical department, faculty of medicine, Aswan University | ||
| 2Department of clinical pathology, faculty of medicine, Aswan university | ||
| 3Gastroenterology and tropical department, faculty of medicine, Assiut University | ||
| Abstract | ||
| Due to the increase in obesity and diabetes, the hepatic failure prevalence is on the rise, as well as the alcohol consumption, and it is a serious condition with an elevated mortality rate. By cirrhosis, chronic hepatic diseases and, extra hepatic conditions, including malignant, metabolic, and psychological disorders, and case variables, like as obesity and older age it has been found that the acute hepatitis or hepatic injury prognosis is influenced. Additionally, one of the main risk factors for the severe liver diseases the is acute insults etiology.Infection with the Hepatitis A virus (HAV) remains one among the globe's most prevalent reasons for acute hepatitis. HAV infection sometimes results in acute liver failure (ALF). This relationship has been denied by a significant amount of investigation, despite the fact that a HAV super infection in a chronic hepatitis C virus (HCV) infection case was found to be related to fulminant hepatitis. Patients without preexisting chronic hepatic diseases barely experience ALF because of HAV. | ||
| Keywords | ||
| HAV; CLD; HAV antibodies | ||
|
Statistics Article View: 31 |
||
